Matching slides 41,369
Current window 33,091-33,120
Pages 1,379
Rows per page 30
Component: Calloutclear collectionreset all

Component

33,091-33,120 of 41,369

filter-aware
07
The slide uses a timeline-based progression (2023 -> Proof of Value -> Platform Innovation) mapped against product generations.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide uses a horizontal icon-based layout to represent the company's core assets, followed by a callout for strategic exploration.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses two distinct bar charts to illustrate market size and federal spending growth.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
06
The slide combines a list of value propositions with a testimonial box.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
13
The slide uses a visual progression arrow to imply growth.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
35
The slide uses a combination of a summary table for clinical endpoints and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
07
The slide uses a strong visual of the product to establish brand identity.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Solution1 hit
08
The slide uses a problem-solution framing, identifying the 'why' (IL-6 is good) and the 'but' (it's unstable), leading to the company's value proposition at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
The slide highlights the clinical importance of IL-6 in various acute conditions.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
The slide details specific event counts and target hazard ratios for OS and PFS endpoints.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
25
Waterfall plot displays individual patient responses; PD indicates Progressive Disease threshold.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
39
The chart shows a clear dose-response/timing-response relationship where earlier treatment leads to lower viral titers.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
06
The slide uses a timeline-annotated line chart to correlate market events with price volatility.Cipher Mining | Investor Presentation Deck | 17 slides · Cipher Mining
Pitch deck Investor relations 1 hit
10
Includes historical data from 2018-2022 and estimates for 2023.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank Beat · Financials1 hit
16
The slide highlights risk mitigation through market and geographic diversity.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
17
The slide uses a hub-and-spoke organizational diagram and a numbered list to explain value-add.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
19
The slide uses a two-column layout to contrast internal management empowerment with external 'preferred buyer' reputation.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
26
Includes specific financial metrics regarding debt, leverage, and cash availability.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
37
The chart shows a scatter plot with a trend line, highlighting CorpAcq's position relative to peers.CorpAcq | SPAC Presentation Deck | 47 slides · CorpAcq
Pitch deck Investment bank 1 hit
03
The slide highlights the impact of an FLC accounting change and FX fluctuations on reported revenue growth.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Financial PerformanceLoop · Logic Chain1 hit
04
The slide highlights the impact of an accounting change (FLC) and FX fluctuations on revenue growth.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Financial PerformanceLoop · Logic Chain1 hit
05
The slide highlights a specific accounting change (FLC) that artificially inflated the GPM by ~100 bps in Q2 2023.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Financial PerformanceLoop · Logic Chain1 hit
06
The slide includes a specific disclaimer regarding an accounting change for FLC revenue starting in Q2 2023.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Financial PerformanceLoop · Logic Chain1 hit
17
The slide includes a specific note regarding an accounting change for FLC revenue starting in Q2 2023.Coupang | Results Presentation Deck | 25 slides · Coupang
Conference presentation Investor relations Beat · Market Size and Segment ResultsLoop · Cost Of Inaction1 hit
02
The slide uses a grid layout to showcase diverse marketing activities including collaborations, influencer partnerships, and platform launches.Crocs | Investor Presentation Deck | 2 slides · Crocs
Conference presentation Investor relations Beat · Interest1 hit
01
Slide 1
The slide uses a linguistic play on the company name to establish brand identity.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
08
The slide uses a comparison to erectile dysfunction to frame the market opportunity.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide highlights clinical trial outcomes and regulatory next steps.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
The slide highlights a key partnership and associated financial milestones.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
20
Includes regulatory status and go-to-market synergy with existing Organon product NEXPLANON.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit